Teva Pharmaceutical Industries reported $57M in Ordinary Share Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Amarin AMRN:US USD 298.6M 3.94M
AstraZeneca AZN:LN USD 387M 0
Biogen BIIB:US USD 100K 0
Coherus Biosciences CHRS:US USD 8K 1000
Emergent Biosolutions EBS:US USD 100K 0
Endo International Ordinary Shares ENDP:US USD 63K 3K
GlaxoSmithKline GSK:LN GBP 1.35B 0
Henry Schein HSIC:US USD 1000K 0
Horizon Pharma HZNP:US USD 23K 0
Lannett LCI:US USD 43K 0
Novartis NOVN:VX USD 890M 0
Pacira Pharmaceuticals PCRX:US USD 46K 0
Patterson Companies PDCO:US USD 977K 7K
Perrigo Ordinary Shares PRGO:US USD 6.94B 27M
Phibro Animal Health PAHC:US USD 4K 0
Revance Therapeutics RVNC:US USD 82K 0
Supernus Pharmaceuticals SUPN:US USD 54K 0
Takeda 4502:JP JPY 1.68T 4M
Teva Pharmaceutical Industries TEVA:US USD 57M 0
Xeris Pharmaceuticals Inc XERS:US USD 14K 0
Zoetis ZTS:US USD 5M 0